Review article: Breaking new ground with Rett syndrome

Journal of Intellectual Disability Research

Volumn 47, Issue 8, 2003, Pages 580-587

  Kerr, Alison M ^a   Ravine, D ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

BRAIN DEVELOPMENT; CELL ACTIVITY; CHROMOSOME XQ; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC COUNSELING; HUMAN; NEUROPHYSIOLOGY; PATHOGENESIS; PHENOTYPE; RETT SYNDROME; REVIEW; SEQUENCE ANALYSIS; SEX DIFFERENCE; SURVIVAL RATE;

CHROMOSOMAL PROTEINS, NON-HISTONE; CHROMOSOMES, HUMAN, X; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; GENE SILENCING; GENETIC COUNSELING; GENETIC SCREENING; HISTONE DEACETYLASES; HUMANS; METHYL-CPG-BINDING PROTEIN 2; NEUROPSYCHOLOGICAL TESTS; REPRESSOR PROTEINS; RETT SYNDROME;

EID: 0242610022     PISSN: 09642633     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2788.2003.00506.x     Document Type: Review

References (74)

1. Amir R. E., Van den Veyver I. B., Schultz R., Malicki D. M., Tran C. Q., Dahle E. J., Philippi A., Timar L., Percy A. K., Motil K. J., Lichtarge O., Smith E. O., Glaze D. G. & Zoghbi H. Y. (2000) Influence of mutation type and X chromosome inactivation on RS phenotypes. Annals of Neurology 47, 670-9.
2. Amir R. E., Van den Veyver I. B., Wan M., Tran C. Q., Francke U. & Zoghbi H. Y. (1999) RS is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics 23, 185-8.
3. Armstrong D. D. (2002) Neuropathology of Rett syndrome. Mental Retardation and Developmental Disability Review 8, 72-6.
4. Armstrong J., Pineda M., Aibar E., Gean E. & Monros E. (2001) Classic Rett syndrome in a boy as a result of somatic mosaicism for a MECP2 mutation. Annals of Neurology 50, 692.
5. Bienvenu T., Carrie A., de Roux N., Vinet M. C., Jonveaux P., Couvert P., Villard L., Arzimanoglou A., Beldjord C., Fontes M., Tardieu M. & Chelly J. (2000) MECP2 mutations account for most cases of typical forms of RS. Human Molecular Genetics 9, 1377-84.
6. Bird A. P. & Wolffe A. P. (1999) Methylation-induced repression - belts, braces, and chromatin. Cell 99, 451-4.
7. Blue M. E., Naidu S. & Johnson M. V. (1999) Altered development og glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Experimental Neurology 156, 345-52.
8. Bourdon V., Philippe C., Bienvenu T., Koenig B., Tardieu M., Chelly J. & Jonveaux P. (2001b) Evidence of somatic mosaicism for a MECP2 mutation in females with Rett syndrome: diagnostic implications. Journal of Medical Genetics 38, 867-71.
9. Bourdon V., Philippe C., Labrune O., Amsallem D., Arnould C. & Jonveaux P. (2001a) A detailed analysis of the MECP2 gene: prevalence of recurrent mutations and gross DNA rearrangements in Rett syndrome patients. Human Genetics 108, 43-50.
10. Burford B., Kerr A. M. & McLeod H. (2003) Nurse recognition of early Deviation in Development in Home videos of infants with Rett Syndrome. Journal of Intellectual Disability Research 47, 589-97.
11. Cheadle J. P., Gill H., Fleming N., Maynard J., Kerr A., Leonard H., Krawczak M., Cooper D. N., Lynch S., Thomas N., Hulten M., Ravine D., Sampson J. R. & Clarke A. (2000) Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Human Molecular Genetics 9, 1119-29.
12. Chen R. Z., Akbarian S., Tudor M. & Jaenisch R. (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurones results in a Rett - like phenotype in mice. Nature Genetics 27, 327-31.
13. Clayton-Smith J., Watson P., Ramsden S. & Black G. C. (2000) Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet 356, 830-2.
14. Cummings D. E. (1986) The genetics of RS: the consequences of a disorder where every case is a new mutation. American Journal of Medical Genet 24, 383-8.
15. Deguchi K., Antalffy B., Twohill L. J., Chakraborty S., Glaze D. G. & Armstrong D. D. (2000) Substance P immunoreactivity in Rett Syndrome. Paediatric Neurology 22, 259-66.
16. Diagnostic Criteria Working Group (1988) Diagnostic criteria for Rett Syndrome. Annals of Neurology 23, 425-8.
17. Drewell R. A., Goddard C. J., Thomas J. O. & Surani M. A. (2002) Methylation-dependent silencing at the H19 imprinting control region by MeCP2. Nucleic Acids Research 30, 1139-44.
18. Elefant C. (2002) Speechless yet communicative: revealing the person behind the disability of Rett Syndrome through clinical research on songs in music therapy. In. Music Therapy in Europe (eds G. Aldridge, G. DiFranco, E. Ruud & T Wigram), pp. 113-28. Ismez, Rome.
19. El-Osta A., Kantharidis P., Zalcberg J. R. & Wolffe A. P. (2002) Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation. Molecular Cell Biology 22, 1844-57.
20. Girard M., Couvert P., Carrie A., Tardieu M., Chelly J., Beldjord C. & Bienvenu T. (2001) Parental origin of de novo MECP2 mutations in RS. European Journal of Human Genetics 9, 231-6.
21. Guy J., Hendrich B., Holmes M., Martin J. E. & Bird A. A. (2001) Mouse Mecp2-null mutation causes neurological symptoms that mimic RS. Nature Genetics 27, 322-6.
22. Hagberg B., Aicardi J., Dias K. & Ramos O. (1983) A progressive syndrome of autism, dementia, ataxia and loss of purposeful hand use in girls: Rett's syndrome - report Of 35 cases. Annals of Neurology 14, 471-9.
23. Hagberg B. & Gillberg G. (1993) Rett variants - rettoid phenotypes. In: RS - Clinical and Biological Aspects. Clinics in Developmental Medicine No. 127 (eds B. Hagberg, M. Anvret, J. Wahlstrom), pp. 40-60. Mac Keith Press, London.
24. Hagberg B. & Hagberg G. (1997) RS: epidemiology and geographical variability. European Child and Adolescent Psychiatry 6, 5-7.
25. Hagberg G., Stenbom Y. & Witt Engerstrom I. (2000) Head growth in Rett Syndrome. Acta Paediatrica 89, 198-202.
26. Hammer S., Dorrani N., Dragich J., Kudo S. & Schanen C. (2002) The phenotypic consequences of MECP2 mutations extend beyond Rett syndrome. Mental Retardation Developmental Disability Research Review 8, 94-8.
27. Hendrich B., Guy J., Ramsahoye B., Wilson V. A. & Bird A. (2001) Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes and Development 15, 710-23.
28. Hoffbuhr K., Devaney J. M., LaFleur B., Sirianni N., Scacheri C., Giron J., Schuette J., Innis J., Marino M., Philippart M., Narayanan V., Umansky R., Kronn D., Hoffman E. P. & Naidu S. (2001) MeCP2 mutations in children with and without the phenotype of RS. Neurology 56, 1486-95.
29. Hoffbuhr K. C., Moses L. M., Jerdonek M. A., Naidu S. & Hoffman E. P. (2002) Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. Mental Retardation Developmental Disabilities Research Reviews 8, 99-105.
30. Ishii T., Makita Y., Ogawa A., Amamiya S., Yamamoto M., Miyamoto A. & Oki J. (2001) The role of different X-inactivation pattern on the variable clinical phenotype with RS. Brain and Development 23, S161-4.
31. Janata P., Birk J. L., Van Horn J. D., Leman M., Tillmann B. & Rharucha J. (2002) The cortical topography of tonal structures underlying Western Music. Science 13. 298(5601), 2167-70.
32. Jones P. L., Veenstra G. J., Wade P. A., Vermaak D., Kass S. U., Landsberger N., Strouboulis J. & Wolffe A. P. (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nature Genetics 19, 187-91.
33. Julu P. O. O., Kerr A. M., Apartopoulos F., Al-rawas S., Witt Engerstrom I., Engerstrom L., Jamal G. A. & Hansen S. (2001) Characterisation of breathing and associated autonomic dysfunction in the Rett Disorder. Archives of Disease in Childhood 85, 29-37.
34. Kaufmann W. E. (2001) Cortical development in RS, molecular, neurochemical and anatomical aspects. In: Rett Disorder and the Developing Brain (eds A. M. Kerr & I. Witt Engerstrom), pp. 85-109. Oxford University Press, Oxford.
35. Kerr A. M. (1987) Report on the RS Workshop: Glasgow Scotland 24-25 May 1986. Journal of Intellectual Deficiency Research 31, 93-113.
36. Kerr A. M. (1992) RS British longitudinal study (1982-1990) and 1990 survey. In: Mental Retardation and Medical Care, April 21-24 1991 (ed. J. J. Roosendaal), pp. 143-5. Uitgeverij Kerckbosch, Zeist.
37. Kerr A. M. (1995) Early clinical signs in the Rett disorder. Neuropediatrics 26, 67-71.
38. Kerr A. M., Armstrong D. D., Prescott R. J., Doyle D. & Kearney D. L. (1997) Analysis of deaths in the British Rett Survey. European Child and Adolescent Psychiatry 6, 71-4.
39. Kerr A. M., Belichenko P., Woodcock T. & Woodcock M. (2001a) Mind and brain in Rett disorder. Brain and Development 23, S44-S9.
40. Kerr A. M., Nomura Y., Armstrong D., Anvret M., Bekichenko P. V., Budden S., Cass H., Christodoulou J., Clarke A., Ellaway C., d'Esposito M., Franke U., Hulten H., Julu P., Leonard H., Naidu S., Schanen C., Webb T., Witt Engerstrom I., Yamashita Y. & Segawa M. (2001b) Guidelines for reporting clinical features in cases with MECP2 mutations. Brain and Development 23, 4.
41. Kerr A. M. & Stephenson J. B. P. (1986) A study of the natural history of RS in 23 girls. American Journal of Medical Genetics 1, 77-83.
42. Kerr A. M. & Witt Engerstrom I. (2001a) The clinical background in Rett disorder and the developing brain. In: Rett Disorder and the Developing Brain (eds A. M. Kerr & I. Witt Engerstrom), pp. 1-25. Oxford University Press, Oxford.
43. Kerr A. M. & Witt Engerstrom I. (2001b) Rett disorder - the developmental perspective. In: Rett Disorder and the Developing Brain (eds A. M. Kerr & I. Witt Engerstrom), pp. 349-59. Oxford University Press, Oxford.
44. Killian W. (1986) On the genetics of Rett Syndrome: analysis of family and pedigree data. American Journal of Medical Genetics 1, 369-76.
45. Klauck S. M., Lindsay S., Beyer K. S., Splitt M., Burn J. & Poustka A. (2002) A mutation hot spot for nonspecific x-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. American Journal of Human Genetics 70, 1034-7.
46. Kleefstra T., Yntema H. G., Oudakker A. R., Romwin T., Sistermans E., Millessen W., van Bokhoven H., de Vries B. B. & Hamel B. C. (2002) De novo MECP2 frameshift mutation in a boy with moderate mental retardation, obesity and gynaecomastia. Clinical Genetics 61, 359-62.
47. Kokura K., Kaul S. C., Wadhwa R., Nomura T., Khan M. M., Shinagawa T., Yasukawa T., Colmenares C. & Ishii S. (2001) The Ski protein family is required for MeCP2-mediated transcriptional repression. Journal of Biological Chemistry 276, 34115-21.
48. Lander E. S., Linton L. M., Birren B., Nusbaum C., Zody M. C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W. et al. (2001) Initial sequencing and analysis of the human genome. Nature 409, 860-921.
49. Lappalainen R. & Rikkonen R. S. (1996) High levels of cerebrospinal fluid glutamate in Rett syndrome. Pediatric Neurology 15, 213-16.
50. Leonard H. & Bower C. (1998) Is the girl with RS normal at birth? Developmental Medicine and Child Neurology 40, 115-21.
51. Lewis J. D., Meehan R. R., Henzel W. J., Maurer-Fogy I., Jeppesen P., Klein F. & Bird A. (1992) Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69, 905-14.
52. Merker B., Bergstrom-Isacsson M. & Witt Engerstrom I. (2001) Music and the Rett Disorder: the Swedish Rett Centre Study. Nordic Journal of Music Therapy 10, 42-53.
53. Naidu S. (1997) Rett Syndrome: a disorder affecting early brain growth. Annals of Neurology 42, 1,3-10.
54. Nan X. & Bird A. (2001) The biological functions of the methyl-CpG binding protein MeCP2 and its implication in RS. Brain and Development 23, S32-7.
55. Nan X., Campoy F. J. & Bird A. (1997) MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88, 471-81.
56. Nan X., Ng H. H., Johnson C. A., Laherty C. D., Turner B. M., Eisenman R. N. & Bird A. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-9.
57. Nan X., Tate P., Li E. & Bird A. (1996) DNA methylation specifies chromosomal localization of MeCP2. Molecular and Cell Biology 16, 414-21.
58. Nielsen J. B., Ravn K. & Schwartz M. (2001) A 77-year-old woman and a preserved speech variant among the Danish Rett patients with mutations in MECP2. Brain and Development 23, S230-2.
59. Nomura Y., Kimura K., Arai H. & Segawa M. (1997) Involvement of the autonomic nervous system in the pathophysiology of Rett Syndrome. European Child and Adolescent Psychiatry 6, 42-6.
60. Percy A. K. (1992) Neurochemistry of the RS. Brain and Development 14, S57-62.
61. Percy A. K. (2002) Clinical trials and treatment prospects. Mental Retardation Developmental Disability 8, 106-11.
62. Rett A. (1966) Uber ein eigenartiges hirnatrophisches Syndrome bei hyperammonamie im Kindsalter. Wiener Medizinische Wochenschrift 116, 723-6.
63. Riikonen R. (2001) Neurotrophic factors in the pathogenesis of RS. In: Rett Disorder and the Developing Brain (eds A. M. Kerr & I. Witt Engerstrom), pp. 125-9. Oxford University Press, Oxford.
64. Shahbazian M. D., Antalffy B., Armstrong D. L. & Zoghbi H. Y. (2002) Insight into RS: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Human Molecular Genetics 111, 115-24.
65. Shahbazian M. D. & Zoghbi H. Y. (2002) Rett syndrome and MeCP2: linking epigenetics and neuronal function. American Journal of Human Genetics 71, 1259-72.
66. Topcu M., Akyerli C., Sayi A., Toruner G. A., Kocoglu S. R., Cimbis M. & Ozcelik T. (2002) Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy. Eropean Journal of Human Genetics 10, 77-81.
67. Trappe R., Laccone F., Cobilanschi J., Meins M., Huppke P., Hanefeld F. & Engel W. (2001) MeCP2 mutations in sporadic cases of RS are almost exclusively of paternal origin. American Journal of Human Genetics 68, 1093-101.
68. Villard L., Cardoso A. K., Chelly P. J., Tardieu P. M. & Fontes M. (2000) Two affected boys in a Rett Syndrome family: clinical and molecular findings. Neurology 55, 1188-93.
69. Wade P. A. (2001) Methyl CpG-binding proteins and transcriptional repression. Bioessays 23, 113-17.
70. Wan M., Lee S. S., Zhang X., Houwink-Manville I., Song H. R., Amir R. E., Budden S., Naidu S., Pereira J. L., Lo I. F., Zoghbi H. Y., Schanen N. C. & Francke U. (1999) Rett Syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. American Journal of Human Genetics 65, 1520-9.
71. 4 hyperacetylation in RS. Human Molecular Genetics 10, 1085-92.
72. Wenk G. L. & Hauss-Wegrzniak B. (1999) Altered cholinergic function in the basal forebrain of girls with Rett syndrome. Neuropediatrics 30, 125-9.
73. Wright M., Van der Linden M. L., Kerr A. M., Burford B., Arrowsmith G. & Middleton R. L. (2003) Motion analysis of stereotyped hand movements in RS. Journal of Intellectual Disability Research 47, 85-9.
74. Zappella M., Meloni I., Longo I., Hayek G. & Renieri A. (2001) Preserved speech variants of the RS: molecular and clinical analysis. American Journal of Medical Genetics 104, 14-22.